{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:15:40Z","timestamp":1787764540145,"version":"build-2784847793"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-05892-6","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T13:01:48Z","timestamp":1746968508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["High prevalence of HLA-B51 and ocular involvement in Beh\u00e7et\u2019s disease: a multicenter cross-sectional study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8720-867X","authenticated-orcid":false,"given":"Shamma Ahmad Al","family":"Nokhatha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1390-7934","authenticated-orcid":false,"given":"Najla","family":"Aljaberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9281-8341","authenticated-orcid":false,"given":"Jawaher Al","family":"Zeyoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6169-7284","authenticated-orcid":false,"given":"Ahlam","family":"Almarzooqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6256-6489","authenticated-orcid":false,"given":"Farah","family":"Soukieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3657-0449","authenticated-orcid":false,"given":"Mumtaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,11]]},"reference":[{"key":"5892_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41927-020-00172-1","volume":"5","author":"M Kiafar","year":"2021","unstructured":"Kiafar M, Faezi ST, Kasaeian A et al (2021) Diagnosis of Beh\u00e7et\u2019s disease: clinical characteristics, diagnostic criteria, and differential diagnoses. BMC Rheumatol 5:2. https:\/\/doi.org\/10.1186\/s41927-020-00172-1","journal-title":"BMC Rheumatol"},{"key":"5892_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/607921","author":"F Davatchi","year":"2012","unstructured":"Davatchi F (2012) Diagnosis\/Classification criteria for Beh\u00e7et\u2019s disease. Pathol Res Int. https:\/\/doi.org\/10.1155\/2012\/607921","journal-title":"Pathol Res Int"},{"key":"5892_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/diagnostics13010041","volume":"13","author":"F Alibaz-Oner","year":"2022","unstructured":"Alibaz-Oner F, Direskeneli H (2022) Update on the diagnosis of Beh\u00e7et\u2019s disease. Diagnostics (Basel) 13:41. https:\/\/doi.org\/10.3390\/diagnostics13010041","journal-title":"Diagnostics (Basel)"},{"key":"5892_CR4","doi-asserted-by":"publisher","unstructured":"Leonardo NM, McNeil J (2015) Beh\u00e7et\u2019s disease: is there geographical variation? A review far from the Silk Road.\u00a0Int J Rheumatol 945262. https:\/\/doi.org\/10.1155\/2015\/945262","DOI":"10.1155\/2015\/945262"},{"key":"5892_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41572-021-00301-1","volume":"7","author":"Y Yazici","year":"2021","unstructured":"Yazici Y, Hatemi G, Bodaghi B et al (2021) Beh\u00e7et syndrome Nat Rev Dis Primers 7:67. https:\/\/doi.org\/10.1038\/s41572-021-00301-1","journal-title":"Beh\u00e7et syndrome Nat Rev Dis Primers"},{"issue":"6","key":"5892_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.autrev.2017.12.006","volume":"17","author":"A Greco","year":"2018","unstructured":"Greco A, De Virgilio A, Ralli M et al (2018) Beh\u00e7et\u2019s disease: new insights into pathophysiology, clinical features, and treatment options. Autoimmun Rev 17(6):567\u2013575. https:\/\/doi.org\/10.1016\/j.autrev.2017.12.006","journal-title":"Autoimmun Rev"},{"key":"5892_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s13317-016-0074-1","volume":"7","author":"MJ Zeidan","year":"2016","unstructured":"Zeidan MJ, Saadoun D, Garrido M, Klatzmann D, Six A, Cacoub P (2016) Beh\u00e7et\u2019s disease physiopathology: a contemporary review. Auto Immun Highlights 7:4. https:\/\/doi.org\/10.1007\/s13317-016-0074-1","journal-title":"Auto Immun Highlights"},{"key":"5892_CR8","doi-asserted-by":"publisher","unstructured":"Be\u00e7a, S, Espinosa G (2021) Clinical manifestations and diagnosis of Beh\u00e7et\u2019s syndrome. EMJ Rheumatol 94\u2013104. https:\/\/doi.org\/10.33590\/emjrheumatol\/21-00037.","DOI":"10.33590\/emjrheumatol\/21-00037"},{"key":"5892_CR9","doi-asserted-by":"publisher","unstructured":"Yurdakul S, Seyahi E, Yazici H (2013) Beh\u00e7et\u2019s syndrome. Oxford Textbook Rheumatol 1132\u20131140. https:\/\/doi.org\/10.1093\/med\/9780199642489.003.0135_update_004","DOI":"10.1093\/med\/9780199642489.003.0135_update_004"},{"key":"5892_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","volume":"82","author":"E Kural-Seyahi","year":"2003","unstructured":"Kural-Seyahi E, Fresko I, Seyahi N et al (2003) The long-term mortality and morbidity of Beh\u00e7et syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60\u201376. https:\/\/doi.org\/10.1097\/00005792-200301000-00006","journal-title":"Medicine (Baltimore)"},{"key":"5892_CR11","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s10067-011-1694-5","volume":"30","author":"F Davatchi","year":"2011","unstructured":"Davatchi F, Chams-Davatchi C, Ghodsi Z et al (2011) Diagnostic value of pathergy test in Beh\u00e7et\u2019s disease according to the change of incidence over time. Clin Rheumatol 30:1151\u20131155. https:\/\/doi.org\/10.1007\/s10067-011-1694-5","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5892_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/rheumatology\/kep350","volume":"49","author":"V Hamuryudan","year":"2010","unstructured":"Hamuryudan V, Hatemi G, Tascilar K et al (2010) Prognosis of Beh\u00e7et\u2019s syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial. Rheumatol (Oxford) 49(1):173\u2013177. https:\/\/doi.org\/10.1093\/rheumatology\/kep350","journal-title":"Rheumatol (Oxford)"},{"issue":"10431","key":"5892_CR13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0140-6736(23)02629-6","volume":"403","author":"G Emmi","year":"2024","unstructured":"Emmi G, Bettiol A, Hatemi G, Prisco D (2024) Beh\u00e7et\u2019s syndrome. Lancet 403(10431):1093\u20131108. https:\/\/doi.org\/10.1016\/S0140-6736(23)02629-6","journal-title":"Lancet"},{"issue":"8697","key":"5892_CR14","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 335(8697):1078\u20131080","journal-title":"Lancet"},{"issue":"3","key":"5892_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"International Team for the Revision of the International Criteria for Beh\u00e7et\u2019s Disease (ITR-ICBD)","year":"2014","unstructured":"International Team for the Revision of the International Criteria for Beh\u00e7et\u2019s Disease (ITR-ICBD) (2014) The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28(3):338\u2013347. https:\/\/doi.org\/10.1111\/jdv.12107","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5892_CR16","unstructured":"International Society for Beh\u00e7et\u2019s Disease (n.d.). https:\/\/behcetdiseasesociety.org\/behcetwsData\/Uploads\/files\/BehcetsDiseaseActivityForm.pdf"},{"issue":"1","key":"5892_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s42358-021-00193-5","volume":"61","author":"FT Elgengehy","year":"2021","unstructured":"Elgengehy FT, Gamal SM, Sobhy N et al (2021) Vasculitis damage index in Beh\u00e7et\u2019s disease. Adv Rheumatol 61(1):33. https:\/\/doi.org\/10.1186\/s42358-021-00193-5","journal-title":"Adv Rheumatol"},{"key":"5892_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001192","volume":"6","author":"M Piga","year":"2020","unstructured":"Piga M, Floris A, Espinosa G et al (2020) Development and preliminary validation of the Beh\u00e7et\u2019s syndrome overall damage index (BODI). RMD Open 6:e001192. https:\/\/doi.org\/10.1136\/rmdopen-2020-001192","journal-title":"RMD Open"},{"key":"5892_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL et al (2019) The REDCap consortium: building an international community of software platform partners. J Biomed Inform 95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208","journal-title":"J Biomed Inform"},{"key":"5892_CR20","doi-asserted-by":"publisher","unstructured":"Sula B, Batmaz I, Ucmak D, Yolbas I, Akdeniz S (2014) Demographical and clinical characteristics of Beh\u00e7et\u2019s disease in southeastern Turkey.\u00a0J Clin Med Res 6:476\u2013481. https:\/\/doi.org\/10.14740\/jocmr1952w","DOI":"10.14740\/jocmr1952w"},{"key":"5892_CR21","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/j.1365-2133.2007.08116.x","volume":"15","author":"E Alpsoy","year":"2007","unstructured":"Alpsoy E, Donmez L, Onder M et al (2007) Clinical features and natural course of Beh\u00e7et\u2019s disease in 661 cases: a multicentre study. Br J Dermatol 15:901\u2013906. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08116.x","journal-title":"Br J Dermatol"},{"key":"5892_CR22","first-page":"S19","volume":"21","author":"CC Zouboulis","year":"2003","unstructured":"Zouboulis CC, Vaiopoulos G, Marcomichelakis N et al (2003) Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Beh\u00e7et\u2019s disease in Greece. Clin Exp Rheumatol 21:S19\u2013S26","journal-title":"Clin Exp Rheumatol"},{"key":"5892_CR23","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.rcreue.2020.01.007","volume":"27","author":"D Padilla-Ortiz","year":"2020","unstructured":"Padilla-Ortiz D, Chamorro-Melo M, Santos AM et al (2020) Beh\u00e7et\u2019s disease: a diagnostic challenge in rheumatology: description of a case series and a review of the literature. Revista Colombiana de Reumatolog\u00eda (English edition) 27:308\u2013316. https:\/\/doi.org\/10.1016\/j.rcreue.2020.01.007","journal-title":"Revista Colombiana de Reumatolog\u00eda (English edition)"},{"key":"5892_CR24","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/rheumatology\/keaa682","volume":"60","author":"HS Ahn","year":"2021","unstructured":"Ahn HS, Kim HJ, Kazmi SZ et al (2021) Familial risk of Beh\u00e7et\u2019s disease among first-degree relatives: a population-based aggregation study in Korea. Rheumatol (Oxford) 60:2697\u20132705. https:\/\/doi.org\/10.1093\/rheumatology\/keaa682","journal-title":"Rheumatol (Oxford)"},{"key":"5892_CR25","first-page":"S96","volume":"23","author":"P Fietta","year":"2005","unstructured":"Fietta P (2005) Beh\u00e7et\u2019s disease: familial clustering and immunogenetics. Clin Exp Rheumatol 23:S96\u2013S105","journal-title":"Clin Exp Rheumatol"},{"key":"5892_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jaut.2009.02.011","volume":"32","author":"D Mendes","year":"2009","unstructured":"Mendes D, Correia M, Barbedo M et al (2009) Beh\u00e7et\u2019s disease: a contemporary review. J Autoimmun 32:178\u2013188. https:\/\/doi.org\/10.1016\/j.jaut.2009.02.011","journal-title":"J Autoimmun"},{"key":"5892_CR27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34867","volume":"15","author":"F Alharthy","year":"2023","unstructured":"Alharthy F, Almaqati AS, Alsulami S, Ahmad A (2023) Beh\u00e7et\u2019s disease in Saudi Arabia: clinical and demographic characteristics. Cureus 15:e34867. https:\/\/doi.org\/10.7759\/cureus.34867","journal-title":"Cureus"},{"key":"5892_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2023.101216","volume":"97","author":"Z Zhong","year":"2023","unstructured":"Zhong Z, Su G, Yang P (2023) Risk factors, clinical features, and treatment of Beh\u00e7et\u2019s disease uveitis. Prog Retin Eye Res 97:101216. https:\/\/doi.org\/10.1016\/j.preteyeres.2023.101216","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"5892_CR29","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1365-4632.2012.05756.x","volume":"53","author":"I Balta","year":"2014","unstructured":"Balta I, Akbay G, Kalkan G, Eksioglu M (2014) Demographic and clinical features of 521 Turkish patients with Beh\u00e7et\u2019s disease. Int J Dermatol 53(5):564\u2013569. https:\/\/doi.org\/10.1111\/j.1365-4632.2012.05756.x","journal-title":"Int J Dermatol"},{"issue":"6","key":"5892_CR30","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/14397595.2018.1558752","volume":"29","author":"F Davatchi","year":"2019","unstructured":"Davatchi F, Shahram F, Chams-Davatchi C et al (2019) Behcet\u2019s disease in Iran: analysis of 7641 cases. Mod Rheumatol 29(6):1023\u20131030. https:\/\/doi.org\/10.1080\/14397595.2018.1558752","journal-title":"Mod Rheumatol"},{"issue":"1","key":"5892_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/1744666X.2019.1705786","volume":"16","author":"AMH Alkazzaz","year":"2020","unstructured":"Alkazzaz AMH, Ebdan WR, Ghoben MK, Kareem ZT, Al-Harbi SJO (2020) Beh\u00e7et\u2019s disease in Iraq: new insights into the clinical and epidemiologic features in Middle-Euphrates region. Expert Rev Clin Immunol 16(1):109\u2013112. https:\/\/doi.org\/10.1080\/1744666X.2019.1705786","journal-title":"Expert Rev Clin Immunol"},{"key":"5892_CR32","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/annrheumdis-2017-eular.4216","volume":"76","author":"R Saito","year":"2017","unstructured":"Saito R et al (2017) Thu0571 the clinical features of 223 behcet\u2019s disease patients in Japan. Ann Rheumatic Dis 76:422. https:\/\/doi.org\/10.1136\/annrheumdis-2017-eular.4216","journal-title":"Ann Rheumatic Dis"},{"key":"5892_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/09273948.2015.1136422","volume":"25","author":"Y Horie","year":"2017","unstructured":"Horie Y, Meguro A, Ohta T et al (2017) HLA-B51 carriers are susceptible to ocular symptoms of Beh\u00e7et disease and the association between the two becomes stronger towards the east along the Silk Road: a literature survey. Ocul Immunol Inflamm 25:37\u201340. https:\/\/doi.org\/10.3109\/09273948.2015.1136422","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"5892_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/BOR.0000000000000846","volume":"34","author":"M Takeno","year":"2022","unstructured":"Takeno M (2022) The association of Beh\u00e7et\u2019s syndrome with HLA-B51 as understood in 2021. Curr Opin Rheumatol 34(1):4\u20139. https:\/\/doi.org\/10.1097\/BOR.0000000000000846","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"5892_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2024.105819","volume":"92","author":"J Sota","year":"2025","unstructured":"Sota J, Ragab G, AlMaglouth I et al (2025) Influence of gender on Beh\u00e7et\u2019s disease phenotype and irreversible organ damage: Data from the International AIDA Network Beh\u00e7et\u2019s Disease Registry. Joint Bone Spine 92(2):105819. https:\/\/doi.org\/10.1016\/j.jbspin.2024.105819","journal-title":"Joint Bone Spine"},{"key":"5892_CR36","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","volume":"77","author":"G Hatemi","year":"2018","unstructured":"Hatemi G, Christensen R, Bang D et al (2018) 2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome. Ann Rheumatic Dis 77:808\u2013818. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213225","journal-title":"Ann Rheumatic Dis"},{"key":"5892_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00296-025-05855-x","volume":"45","author":"L Prtenja\u010da","year":"2025","unstructured":"Prtenja\u010da L, Mayer M, Karanovi\u0107 B et al (2025) Demographics and clinical manifestations in patients with Beh\u00e7et\u2019s disease: a retrospective observational study from a non-endemic country. Rheumatol Int 45:102. https:\/\/doi.org\/10.1007\/s00296-025-05855-x","journal-title":"Rheumatol Int"},{"key":"5892_CR38","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1080\/14397595.2021.1886623","volume":"31","author":"AM Mahdavi","year":"2021","unstructured":"Mahdavi AM, Khabbazi A, Hajialilo M (2021) Long-term outcome and predictors of remission in Beh\u00e7et\u2019s disease in daily practice. Modern Rheumatol 31:1148\u20131157. https:\/\/doi.org\/10.1080\/14397595.2021.1886623","journal-title":"Modern Rheumatol"},{"key":"5892_CR39","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.reumae.2021.03.011","volume":"18","author":"L Serpa Pinto","year":"2022","unstructured":"Serpa Pinto L, Xavier Pires S, Silva B, Farinha F, Vasconcelos C, Ara\u00fajo Correia J (2022) Predictive factors of severe Beh\u00e7et\u2019s disease: a longitudinal, prospective cohort followed between 1981\u20132020. Rheumatol Clin (English edition) 18:410\u2013415. https:\/\/doi.org\/10.1016\/j.reumae.2021.03.011","journal-title":"Rheumatol Clin (English edition)"},{"issue":"4","key":"5892_CR40","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/medicina60040562","volume":"60","author":"S Lavalle","year":"2024","unstructured":"Lavalle S, Caruso S, Foti R et al (2024) Beh\u00e7et\u2019s disease, pathogenesis, clinical features, and treatment approaches: a comprehensive review. Medicina (Kaunas) 60(4):562. https:\/\/doi.org\/10.3390\/medicina60040562","journal-title":"Medicina (Kaunas)"},{"issue":"5","key":"5892_CR41","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s10165-009-0200-2","volume":"19","author":"F Davatchi","year":"2009","unstructured":"Davatchi F, Sadeghi Abdollahi B, Tehrani Banihashemi A et al (2009) Colchicine versus placebo in Beh\u00e7et\u2019s disease: randomized, double-blind, controlled crossover trial. Mod Rheumatol 19(5):542\u2013549. https:\/\/doi.org\/10.1007\/s10165-009-0200-2","journal-title":"Mod Rheumatol"},{"key":"5892_CR42","doi-asserted-by":"publisher","unstructured":"Hatemi G, Mahr A, Takeno M, et al (2021) Apremilast for oral ulcers associated with active Beh\u00e7et\u2019s syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial. Clin Exp Rheumatol 39 Suppl 132(5):80\u201387. https:\/\/doi.org\/10.55563\/clinexprheumatol\/ra8ize","DOI":"10.55563\/clinexprheumatol\/ra8ize"},{"key":"5892_CR43","doi-asserted-by":"publisher","unstructured":"Hamuryudan V, Ozyazgan Y, Hizli N, Mat C, Yurdakul S, T\u00fcz\u00fcn Y, Senocak M, Yazici H (1997) Azathioprine in Beh\u00e7et\u2019s syndrome: effects on long-term prognosis. Arthritis Rheum 40:769\u2013774.  https:\/\/doi.org\/10.1002\/art.1780400425","DOI":"10.1002\/art.1780400425"},{"key":"5892_CR44","doi-asserted-by":"publisher","unstructured":"Saadoun D, Maalouf G, Vieira M, et al (2024) Infliximab versus cyclophosphamide for severe Beh\u00e7et\u2019s syndrome. NEJM Evid 3(11):EVIDoa2300354. https:\/\/doi.org\/10.1056\/EVIDoa2300354","DOI":"10.1056\/EVIDoa2300354"},{"issue":"3","key":"5892_CR45","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00296-025-05806-6","volume":"45","author":"A Arida","year":"2025","unstructured":"Arida A, Markomichelakis N, Fragoulis GE et al (2025) Very long-term remission in Behcet\u2019s disease following withdrawal of anti-TNF treatment exceeds relapses: a reappraisal of an outcome study. Rheumatol Int 45(3):60. https:\/\/doi.org\/10.1007\/s00296-025-05806-6","journal-title":"Rheumatol Int"},{"key":"5892_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.639404","volume":"8","author":"T Ergun","year":"2021","unstructured":"Ergun T (2021) Pathergy phenomenon Front Med (Lausanne) 8:639404. https:\/\/doi.org\/10.3389\/fmed.2021.639404","journal-title":"Pathergy phenomenon Front Med (Lausanne)"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05892-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05892-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05892-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T09:30:13Z","timestamp":1750239013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05892-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["5892"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05892-6","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,11]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this study. The data supporting the findings of this study are available upon request from the corresponding author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Tawam Human Ethics Committee, Sheikh Shakhbout Medical City Ethics Committee (reference SSMCREG-322), and MOHAP Research ethical committee (MOHAP\/DXB-REC\/ J.S.S\/No. 118\/ 2024.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}}],"article-number":"140"}}